For World Health Day, learn how Johnson & Johnson’s commitment to Diversity, Equity and Inclusion is helping to deliver transformational cancer treatments and solutions that reach the patients who need them most.
Algorithms, artificial intelligence, machine learning and other technologies are transforming the way physicians identify, treat and manage diseases. Here’s how Johnson & Johnson is putting the latest tools to work.
Hidden in large amounts of digital information—such as anonymized medical records—may be the keys to transforming the future of healthcare. Troy C. Sarich, Ph.D., Johnson & Johnson's Chief Commercial Data Science Officer, shares how the company is carefully collecting, analyzing and harnessing this information to improve the health of people everywhere.
Artificial intelligence-enabled mobile screening units. Nasal swab genomic tests. Diagnostics that pair the right treatment with the right patient. For National Cancer Prevention Month, Johnson & Johnson researchers share the progress that's being made to thwart the #1 cancer killer.
A potential COVID-19 vaccine. Passionate efforts toward achieving racial and social justice. Smarter, more sustainable product packaging. These are just a few of the resolutions company change makers are aiming to bring to light this year—and they're already hard at work on them.
Johnson & Johnson develops consumer products, medical devices and pharmaceuticals—and McEvoy is at the helm of its global Medical Devices Companies. She shares how she has navigated the pandemic, grown professionally and personally as a result, and helped impact the lives of millions during this unique moment in history.
A new report from the American Cancer Society sheds light on declining death rates from cancer—especially lung cancer. We asked an expert on the disease to break down the data, and share what's to come in better detecting and preventing it.
From robotics solutions for orthopedic surgery to the potential to bring new hope to patients living with multiple myeloma through CAR-T, these are just some of the cutting-edge projects that these visionaries think could potentially help propel healthcare forward around the globe.
A team of scientists, including those from Janssen andthe Lung Cancer Initiative at Johnson & Johnson, found that biomarkers related to the immune system may be able to aid doctors in identifying high-risk lung cancer patients—and treating them—at the earliest stage of the disease.
Frederic Moll, M.D., has been called "the father of robotic surgery" for good reason—his inventions have helped pave the way for improved surgical procedures for decades. His new challenge: an innovation that has the potential to diagnose and treat disease at the same time.
Some 20% of people diagnosed with the disease haven't touched a cigarette. For Healthy Lung Month, scientists who've dedicated their research to defeating lung cancer discuss why early detection is so key—and what you can do to protect yourself.
Trillions of beneficial bacteria live in and all around us. What if we could use them to our advantage, to do everything from prevent diabetes to reduce inflammation? Dirk Gevers, Ph.D., Global Head of the Janssen Human Microbiome Institute, shares how his team is already well on that research path.
From breakthrough work to eradicate some of the world's deadliest diseases to advancements in cutting-edge health technology, see just some of the ways Johnson & Johnson is working to help change the trajectory of health for humanity.